Government Policy and Treasury

Budget 2019: R&D Tax Incentive Programme Cost Reductions with No Specific Detail

April 3rd, 2019

The Federal Government handed down their budget on 2 April 2019 and whilst there appeared to be no specific new changes proposed to the R&D Tax Incentive, the forward estimates cost of the programme is projected to reduce by $1.35 billion. It is not clear whether this cost reduction is a product of: The legislative changes proposed in the last federal budget being introduced. These changes were recently the subject of a Senate Economics Committee review that recommended the changes […]

Read More

Opposition Policy on R&D Tax Incentive

January 17th, 2019

With a federal election due over the coming months, the opposition labor party have made some announcements with respect to their policy on the R&D Tax incentive. The original R&D tax incentive legislation was enacted whilst the labor was in power. Labor have committed to maintain the R&D tax incentive as the primary lever to induce business R&D. Labor have indicated they would look to incorporate the collaboration premium within the R&D tax incentive for expenditure on activities undertaken in […]

Read More

Swanson Reed – R&D Legislative Amendment Submission

July 25th, 2018

The Australian Government announced a reform of the R&D Tax Incentive program as part of the 2018-19 Federal Budget. Swanson Reed is of the view that stable and generous support for R&D must be maintained to give companies confidence to invest in long-term innovation strategies. We have provided feedback in response to the draft legislation of amendments to the Research and Development Tax Incentive.  To read our submission to the Treasury, please click the link below: Swanson Reed – R&D […]

Read More

Draft Legislation Released for R&D Tax Incentive

July 3rd, 2018

The Government announced on 8 May 2018 that the Research and Development Tax Incentive (R&DTI) would be reformed and that changes would apply from 1 July 2018. Draft legislation has been released regarding amendments to the R&DTI. Stakeholder feedback is encouraged and responses can be submitted until 26 July 2018. Changes to the Bill include: Increasing the R&D expenditure threshold from $100 to $150 million; Introducing a $4 million cap on annual cash refunds (the cap excludes clinical trials). Refunds over […]

Read More

Email this job

[recaptcha]